A highly contagious stomach bug, sometimes called the “winter vomiting disease,” is circulating again this year. Rates of norovirus have ticked up nationwide, according to wastewater data. The ...

Norovirus treatment exerts a significant burden on Veterans Health Administration (VHA) spending, totalling $28 million in costs when extrapolated annually. That is according to an October study ...

Subject enrollment expected to begin in Q1 2026 CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral ...

Norovirus, the infamous "winter vomiting disease," is surging again across the United States. Norovirus is a highly contagious stomach bug that causes sudden, often violent bouts of diarrhea and ...

There are currently no approved vaccines or treatments for norovirus infection Cocrystal’s CDI-988 is the first antiviral for the potential prevention and treatment of viral gastroenteritis caused by ...

Some Winter Olympics athletes are falling ill with norovirus, and Team USA says it’s staying “dialed in” to curb the spread of the common stomach bug.

It’s the holiday guest no one invited. The notorious “winter vomiting disease” is spreading rapidly across the country, with cases of the potentially deadly virus doubling over the past few months as ...

WHEELING, W.Va. (WTRF) – The Wheeling-Ohio County Health Department says recent wastewater tests show high levels of COVID-19 ...

BOTHELL, Wash., July 10, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc (COCP). (Nasdaq: COCP) announces that its first-in-class pan-viral protease inhibitor CDI-988 has been selected for an oral ...

HIEs were used to identify why the growth of norovirus in culture stops and to determine methods to maintain growth.

Health chiefs are urging vigilance as confirmed cases have more than doubled compared to last year, with alcohol-based hand ...